Polymerase Acidic Endonuclease Inhibitor [EPC] - N0000193852

Pharmacologic Code	N0000193852
Pharmacologic Name	Polymerase Acidic Endonuclease Inhibitor
Pharmacologic Uses	polymerase acidic (PA) endonuclease inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 5 products whose active ingredient are classified under the same pharmacologic class Polymerase Acidic Endonuclease Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	50242-583	Xofluza	Non-Proprietary Name: Baloxavir Marboxil	Granule, For Solution	Oral	Genentech, Inc.	ACTIVE
	50242-599	Xofluza	Non-Proprietary Name: Baloxavir Marboxil	Granule, For Suspension	Oral	Genentech, Inc.	ACTIVE
	50242-617	Xofluza	Non-Proprietary Name: Baloxavir Marboxil	Granule, For Suspension	Oral	Genentech, Inc.	ACTIVE
	50242-860	Xofluza	Non-Proprietary Name: Baloxavir Marboxil	Tablet, Film Coated	Oral	Genentech, Inc.	ACTIVE
	50242-877	Xofluza	Non-Proprietary Name: Baloxavir Marboxil	Tablet, Film Coated	Oral	Genentech, Inc.	ACTIVE